{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:16:57Z","timestamp":1784557017895,"version":"3.55.0"},"reference-count":10,"publisher":"Bioscientifica","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Pituitary carcinoma is a rare type of malignancy and only accounts for 0.1\u20130.2% of all pituitary tumours. Most pituitary carcinomas are hormonally active and they are mostly represented by corticotroph and lactotroph carcinomas. Corticotroph carcinoma can present as symptomatic Cushing\u2019s disease or can evolve from silent corticotroph adenoma which is not associated with clinical or biochemical evidence of hypercortisolism. We hereby present a case of a bone-metastasized corticotroph pituitary carcinoma masquerading as an ectopic adrenocorticotropic hormone (ACTH) syndrome in a patient with a history of a non-functioning pituitary macro-adenoma. Our patient underwent two transsphenoidal resections of the primary pituitary tumour followed by external beam radiation therapy. Under hydrocortisone substitution therapy she developed ACTH-dependent hypercortisolism without arguments for recurrence on pituitary MRI and without central-to-peripheral ACTH-gradient on inferior petrosal sinus sampling, both suggesting ectopic production. Ultimately, she was diagnosed with an ACTH-secreting vertebral metastasis originating from the primary pituitary tumour. This case report demonstrates the complex pathophysiology of pituitary carcinoma and the long diagnostic work-up. Certain features in pituitary adenoma should raise the suspicion of malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>The diagnosis of pituitary carcinoma can only be made based on documented metastasis, therefore, due to the often long latency period between the detection of the primary tumour and the occurrence of metastasis, the diagnostic work-up most often spans over multiple years.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Pituitary carcinoma including corticotroph carcinoma is very rare in contrast to pituitary adenoma and only accounts for 0.1\u20130.2% of all pituitary tumours.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Histopathology in pituitary adenoma should certainly accomplish the following goals: accurate tumour subtyping and assessment of tumoural proliferative potential.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Repeated recurrence of pituitary adenoma after surgical resection, a discrepancy between biochemical and radiological findings, resistance to medical and radiation therapy, and silent tumours becoming functional are all hallmarks of pituitary carcinoma.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Silent corticotroph adenomas are non-functioning pituitary adenomas that arise from T-PIT lineage adenohypophyseal cells and that can express adrenocorticotropic hormone on immunohistochemistry, but are not associated with biochemical or clinical evidence of hypercortisolism. Silent corticotroph adenomas exhibit a more aggressive clinical behaviour than other non-functioning adenomas.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Treatment options for corticotroph carcinoma include primary tumour resection, radiation therapy, medical therapy, and chemotherapy. Sometimes bilateral adrenalectomy is necessary to achieve sufficient control of the cortisol excess.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-21-0168","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T09:00:18Z","timestamp":1648026018000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Corticotroph pituitary carcinoma with skeletal metastases masquerading as ectopic ACTH syndrome: a long and winding road to diagnosis"],"prefix":"10.1530","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-0456","authenticated-orcid":true,"given":"Eug\u00e9nie","family":"Van Mieghem","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, GZA Hospitals, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent","family":"Intan-Goey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, GZA Hospitals, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Buffet","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, GZA Hospitals, Antwerpen, Belgium"},{"name":"Department of Pathological Anatomy, ZNA Hospitals, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lammens","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, University Hospital of Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Loo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, GZA Hospitals, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Abrams","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, GZA Hospitals, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1210\/jc.2011-2031","article-title":"Clinical Review: Pituitary carcinoma: difficult diagnosis and treatment","volume":"96","author":"Heaney","year":"2011","unstructured":"Heaney APClinical Review: Pituitary carcinoma: difficult diagnosis and treatment. Journal of Clinical Endocrinology and Metabolism2011963649\u20133660. (https:\/\/doi.org\/10.1210\/jc.2011-2031)10.1210\/jc.2011-2031"},{"key":"bib2","series-title":"Nature Reviews: Endocrinology","first-page":"671","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","unstructured":"Raverot GIlie MDLasolle HAmodru VTrouillas JCastinetti FBrue T. Aggressive pituitary tumours and pituitary carcinomas. Nature Reviews: Endocrinology202117671\u2013684. (https:\/\/doi.org\/10.1038\/s41574-021-00550-w)"},{"key":"bib3","series-title":"Endocrine Pathology","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","unstructured":"Mete OLopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocrine Pathology201728228\u2013243. (https:\/\/doi.org\/10.1007\/s12022-017-9498-z)10.1007\/s12022-017-9498-z"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1210\/jc.2004-2231","article-title":"Clinical review: diagnosis and management of pituitary carcinomas","volume":"90","author":"Kaltsas","year":"2005","unstructured":"Kaltsas GANomikos PKontogeorgos GBuchfelder MGrossman AB. Clinical review: diagnosis and management of pituitary carcinomas. Journal of Clinical Endocrinology and Metabolism2005903089\u20133099. (https:\/\/doi.org\/10.1210\/jc.2004-2231)10.1210\/jc.2004-2231"},{"key":"bib5","series-title":"Neurosurgery","first-page":"1066","article-title":"Pituitary carcinoma: a clinicopathological review","volume":"56","author":"Scheithauer","year":"2005","unstructured":"Scheithauer BWKurtkaya-Yap\u0131c\u0131er OKovacs KTYoung Jr WFLloyd RV. Pituitary carcinoma: a clinicopathological review. Neurosurgery2005561066\u20131074; discussion 1066. (https:\/\/doi.org\/10.1227\/01.NEU.0000214117.87793.6F)"},{"key":"bib6","series-title":"Endocrine Pathology","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1385\/EP:12:3:329","article-title":"Corticotroph pituitary carcinoma: case report and literature review","volume":"12","author":"Holthouse","year":"2001","unstructured":"Holthouse DJRobbins PDKahler RKnuckey NPullan P. Corticotroph pituitary carcinoma: case report and literature review. Endocrine Pathology200112329\u2013341. (https:\/\/doi.org\/10.1385\/ep:12:3:329)10.1385\/EP:12:3:329"},{"key":"bib7","series-title":"Journal of Neurosurgery","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","article-title":"Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence","volume":"135","author":"Strickland","year":"2021","unstructured":"Strickland BAShahrestani SBriggs RGJackanich ATavakol SHurth KShiroishi MSLiu CJCarmichael JDWeiss MSilent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. Journal of Neurosurgery20211351706\u20131713. (https:\/\/doi.org\/10.3171\/2020.10.JNS203236)10.3171\/2020.10.JNS203236"},{"key":"bib8","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","unstructured":"Raverot GBurman PMcCormack AHeaney APetersenn SPopovic VTrouillas JDekkers OM & European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European Journal of Endocrinology2018178G1\u2013G24. (https:\/\/doi.org\/10.1530\/EJE-17-0796)10.1530\/EJE-17-0796"},{"key":"bib9","series-title":"Journal of Internal Medicine","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/joim.12975","article-title":"Current management of Cushing\u2019s disease","volume":"286","author":"Tritos","year":"2019","unstructured":"Tritos NABiller BMK. Current management of Cushing\u2019s disease. Journal of Internal Medicine2019286526\u2013541. (https:\/\/doi.org\/10.1111\/joim.12975)10.1111\/joim.12975"},{"key":"bib10","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","unstructured":"McCormack ADekkers OMPetersenn SPopovic VTrouillas JRaverot GBurman P & ESESurvey Collaborators. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. European Journal of Endocrinology2018178265\u2013276. (https:\/\/doi.org\/10.1530\/EJE-17-0933)10.1530\/EJE-17-0933"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2022\/1\/EDM21-0168.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2022\/1\/EDM21-0168.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2022\/1\/EDM21-0168.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:49Z","timestamp":1784555269000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1530\/edm-21-0168","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}